Fredrick Chalinga: The Reality of Massive Transfusion in Emergency Medicine
Fredrick Chalinga, Medical Technologist at Aga Khan University Hospital, shared a post on LinkedIn:
“When Blood can’t Wait: Massive Transfusion Decisions under Pressure.
‘Emergency transfusion is where science, speed, and clinical judgment meet.’
In massive hemorrhage, the priority is simple, keep the patient alive while minimizing transfusion risk.
When there is no history of clinically significant alloantibodies, ABO/Rh type-specific blood is usually issued rapidly to support ongoing resuscitation.
But real emergencies are rarely perfect.
There are moments when an Rh-negative patient may receive Rh-positive blood, not because it is ideal, but because delaying transfusion could cost a life.
This may occur when: Massive bleeding is ongoing, Rh-negative blood stocks are critically low, additional compatible units are unlikely to arrive in time.
These decisions are never taken lightly.
Consultation with the Consultant Hematologist is essential before issuing Rh-positive blood to an Rh-negative recipient.
Special caution must always be exercised in Rh-negative females of childbearing potential because of the risk of anti-D alloimmunization and future hemolytic disease of the fetus and newborn (HDFN).
Likewise, patients with existing anti-D antibodies should never receive Rh-positive blood.
In emergency-release situations:
- The attending physician must be informed
- All emergency-release documentation must be signed
- Uncrossmatched blood forms or blood transfusion monitoring chart forms must accompany issued units
- Transition back to Rh-negative compatible blood should occur as soon as possible
In trauma bays, operating theatres, maternity emergencies, and intensive care units, blood bank professionals make rapid high-stakes decisions every day.
The challenge is not just providing blood quickly it is providing the safest possible blood under extreme pressure.
Transfusion medicine is often a balance between ideal compatibility and urgent survival.
- Save life first
- Reduce avoidable immunization risks
- Maintain communication and documentation
- Return to compatible support as early as possible
- Never compromise patient safety principles, even during emergencies
Right blood. Right judgment. Right time.”

Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients